Education
About Us
Working with TipRanks
Follow Us
Medicover AB (SE:MCOV.B)
:MCOV.B
Earnings Data
Report Date
Apr 29, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
1.55Last Year’s EPS
1.42Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call emphasized multiple substantial operational and financial improvements—double-digit organic growth, stronger margins, large EBITDAaL expansion, improved cash generation, higher ROIC, deleveraging and a recommended dividend increase. These positive outcomes were balanced against a set of manageable near-term headwinds: Germany pricing reform, a strike-related disruption in India, losses from newly opened hospitals, seasonal softness and incomplete realization of some acquisition synergies. Management reiterated confidence with ambitious 3-year targets and detailed integration progress. On balance, the positives (broad revenue and profit growth, cash and return metrics, successful execution vs targets) outweigh the near-term challenges.Company Guidance
Strong top-line growth (Q4 and FY '25)
Q4 revenue EUR 611m with organic growth of 10.6%. Full year revenue grew 13.7% (organic 12.7%), delivering a revenue base just under EUR 2.4bn.
EBITDAaL and margin expansion
Q4 EBITDAaL EUR 57.0m, up 30% year-over-year; EBITDAaL margin improved to 9.3% (up 140 bps YoY). Full year EBITDAaL EUR 243.1m, up 40% (margin up 190 bps YoY).
Profitability and EPS improvement
Q4 EBIT EUR 35.2m (margin 5.7%, +150 bps YoY). Net profit in Q4 EUR 17.3m (margin 2.8%). FY EPS EUR 0.514 versus EUR 0.112 prior year, reflecting strong flow-through.
Cash generation and returns
Net operating cash in Q4 EUR 100m, up 56% YoY; full year operating cash EUR 343.7m, up 31% YoY. ROIC nearly doubled from 6.7% at end-FY24 to ~13% at end-FY25.
Business-unit performance—Healthcare Services
Healthcare organic revenue +11% in the quarter (price +6%, volume +5%); Healthcare EBITDAaL EUR 72.5m, up 23%, with margin expansion of ~200 bps in the quarter.
Business-unit performance—Diagnostics
Diagnostics revenue +13.5% (organic ~9.3%); test volumes increased ~17.6%. Diagnostics EBITDA EUR 33.3m with margin improving to 17.3% (up ~120 bps YoY).
Operational progress and M&A integration
SYNLAB and Sports & Wellness acquisitions are being integrated; SYNLAB implementation described as 'almost complete' and Sports & Wellness contributing meaningfully to fee-for-service growth.
Capital deployment and network expansion
Q4 CapEx ~EUR 57m; full year CapEx ~6.7% of revenues. Added ~77,000 sqm medical space in FY25, ending the year at ~986,000 sqm and expected to pass 1,000,000 sqm in Q1.
Balance sheet and shareholder returns
Leverage improved to 3.1x from 3.4x a year ago. Board recommended a dividend increase; medium-term policy reiterated (dividends ~50% or lower of net profit target).
Ambitious 3-year targets
Management set 2028 targets: organic revenues > EUR 3.25bn, adjusted organic EBITDA > EUR 600m, leverage at or below 3x, EBIT > EUR 290m, adjusted EBITDAaL > EUR 430m.
SE:MCOV.B Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
SE:MCOV.B Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 10, 2026 | kr202.50 | kr219.00 | +8.15% |
Nov 05, 2025 | kr243.50 | kr237.50 | -2.46% |
Jul 24, 2025 | kr257.50 | kr285.00 | +10.68% |
Apr 29, 2025 | kr212.00 | kr231.85 | +9.37% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Medicover AB (SE:MCOV.B) report earnings?
Medicover AB (SE:MCOV.B) is schdueled to report earning on Apr 29, 2026, Before Open (Confirmed).
What is Medicover AB (SE:MCOV.B) earnings time?
Medicover AB (SE:MCOV.B) earnings time is at Apr 29, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Medicover AB stock?
The P/E ratio of Medicover AB is N/A.
What is SE:MCOV.B EPS forecast?
SE:MCOV.B EPS forecast for the fiscal quarter 2026 (Q1) is 1.55.